Citadel Advisors’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,440
| Closed | -$79.1K | – | 6053 |
|
|
2024
Q1 | $79.1K | Buy |
+13,440
| New | +$79.1K | ﹤0.01% | 5169 |
|
|
2023
Q4 | – | Sell |
-11,032
| Closed | -$61.1K | – | 6001 |
|
|
2023
Q3 | $61.1K | Buy |
11,032
+6,874
| +165% | +$38.1K | ﹤0.01% | 5004 |
|
|
2023
Q2 | $45.4K | Sell |
4,158
-16,229
| -80% | -$177K | ﹤0.01% | 5024 |
|
|
2023
Q1 | $254K | Buy |
+20,387
| New | +$254K | ﹤0.01% | 4432 |
|
|
2022
Q2 | – | Sell |
-3,532
| Closed | -$63K | – | 6138 |
|
|
2022
Q1 | $63K | Buy |
+3,532
| New | +$63K | ﹤0.01% | 5830 |
|
|
2021
Q4 | – | Sell |
-5,551
| Closed | -$111K | – | 6554 |
|
|
2021
Q3 | $111K | Buy |
+5,551
| New | +$111K | ﹤0.01% | 5803 |
|
|
2021
Q1 | – | Sell |
-5,381
| Closed | -$87K | – | 6332 |
|
|
2020
Q4 | $87K | Buy |
+5,381
| New | +$87K | ﹤0.01% | 4723 |
|
|
2019
Q2 | – | Sell |
-1,355
| Closed | -$23K | – | 4711 |
|
|
2019
Q1 | $23K | Buy |
+1,355
| New | +$23K | ﹤0.01% | 4386 |
|
|
2018
Q4 | – | Sell |
-8,862
| Closed | -$104K | – | 4565 |
|
|
2018
Q3 | $104K | Buy |
8,862
+5,956
| +205% | +$69.9K | ﹤0.01% | 3898 |
|
|
2018
Q2 | $41K | Buy |
+2,906
| New | +$41K | ﹤0.01% | 3934 |
|
|
2018
Q1 | – | Sell |
-940
| Closed | -$24K | – | 4035 |
|
|
2017
Q4 | $24K | Buy |
+940
| New | +$24K | ﹤0.01% | 3747 |
|
|
2017
Q3 | – | Sell |
-84
| Closed | -$4K | – | 3731 |
|
|
2017
Q2 | $4K | Sell |
84
-228
| -73% | -$10.9K | ﹤0.01% | 3591 |
|
|
2017
Q1 | $30K | Buy |
+312
| New | +$30K | ﹤0.01% | 3469 |
|
|
2016
Q3 | – | Sell |
-133
| Closed | -$34K | – | 3631 |
|
|
2016
Q2 | $34K | Buy |
+133
| New | +$34K | ﹤0.01% | 3110 |
|